Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock, trading in the BE series, hit its maximum allowed daily gain of 5%, closing at Rs 1701.9 after opening with a gap up of 5%. The price band of 5% capped the rally, effectively freezing trading at the ceiling price. This scenario indicates unfilled demand, as buyers were willing to purchase shares at the upper limit but sellers were absent. The narrow intraday range of just Rs 0.1 between the high and low prices further underscores the price lock at the circuit level. Such a price band is typical for stocks in this segment, and the circuit mechanism ensures orderly trading by preventing excessive volatility. Venus Remedies Ltd’s upper circuit day reflects a strong buying interest that the market structure could not fully accommodate — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes?

Delivery and Volume Analysis

Despite the upper circuit, total traded volume was 0.18393 lakh shares, translating to a turnover of approximately Rs 3.10 crore. This volume is mechanically suppressed due to the price lock, a common feature on circuit days. However, the delivery volume data reveals a contrasting story. Delivery volume on 2 Sep was 1,970 shares, which is down by 32.89% against the 5-day average delivery volume. This decline in delivery volume suggests that the recent surge may have a speculative element, with fewer shares being taken into long-term holding. The delivery data is the most revealing metric on a circuit day, and in this case, the falling delivery volume tempers the conviction narrative — is this a genuine momentum or a liquidity-driven spike?

Moving Averages and Trend Context

Venus Remedies Ltd is trading above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning confirms a bullish trend that preceded the circuit event. The stock has also been on a two-day consecutive gain streak, rising 6.3% over this period, signalling sustained buying pressure. The upper circuit day can thus be seen as an amplification of an already positive trend rather than an isolated spike. The technical setup supports the price action, but the delivery volume decline introduces a note of caution.

Liquidity and Market Capitalisation Context

With a market capitalisation of Rs 2,274.93 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is modest, with the stock liquid enough for a trade size of Rs 0.09 crore based on 2% of the 5-day average traded value. This limited liquidity means that while the upper circuit is a strong signal of demand, the thin order book and small trade sizes pose a liquidity risk. Investors should be aware that entering or exiting sizeable positions could be challenging without impacting the price. The circuit lock amplifies this effect, as the price ceiling restricts normal price discovery. The circuit is hit and buyers are still queuing — but with near-zero liquidity and a Rs 2,274 crore market cap, should you be chasing Venus Remedies Ltd?

Intraday Price Action

The intraday price range was exceptionally narrow at Rs 0.1, with the stock touching a high of Rs 1701.9 and a low of Rs 1620. This tight range is typical of circuit-bound stocks, where the price is locked at the upper limit for most of the session. The opening gap up of 5% set the tone for the day, and the stock maintained that level without significant retracement. This price behaviour reflects the mechanical effect of the circuit rather than a broad trading range, limiting the scope for intraday volatility.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the micro-cap status suggests a smaller scale compared to industry giants, the company’s consistent price strength and growth trajectory have been noted. The recent price action aligns with the sector’s modest 1-day return of -0.08%, with Venus Remedies Ltd outperforming both the sector and the Sensex, which gained 0.40% on the same day.

Conclusion: What the Circuit, Delivery, and Trend Data Signal

The upper circuit hit at a 5% gain capped the session for Venus Remedies Ltd, signalling strong buying interest that exceeded the price band’s allowance. The stock’s position above all major moving averages confirms a bullish trend, and the two-day consecutive gains reinforce this momentum. However, the decline in delivery volume tempers the conviction story, suggesting some speculative trading alongside genuine demand. The micro-cap status and limited liquidity further caution that while the price action is impressive, the ability to transact large volumes without price impact remains constrained. This liquidity risk is a critical factor for investors considering exposure to Venus Remedies Ltd — after a 5% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Key Data at a Glance

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →